Where Discovery Begins
ADCC FcγRIIIa(158V) NK-92 Cell Line
Cat. No.
GM-C44572
Size
2 vials
Quote
Specifications
Data Display
Materials
Cell Culture
Sequence
Related products
Specifications
Cat. No GM-C44572
Product ADCC FcγRIIIa(158V) NK-92 Cell Line
Description ADCC FcγRIIIa(158V) NK-92 Cell Line is a clonal stable NK-92 cell line that constitutively expresses the Human FcγRIIIa(158V) gene, constructed using electroporation technology.
Product Format 1 vial of frozen cells
Quantity 2E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human FcγRIIIa(158V)
Gene ID/Uniprot ID P08637 (p.F176V)
Host Cell NK-92
Recovery Medium NK-92 cell-specific medium supplemented with 100 U/mL IL-2
Growth medium NK-92 cell-specific medium supplemented with 100 U/mL IL-2
Note Cells should be cultured using Procell-CM-0530 NK-92 Cell Culture Medium.
Freezing Medium 90% FBS+10% DMSO
Growth properties Suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C44572
Product ADCC FcγRIIIa(158V) NK-92 Cell Line
Description ADCC FcγRIIIa(158V) NK-92 Cell Line is a clonal stable NK-92 cell line that constitutively expresses the Human FcγRIIIa(158V) gene, constructed using electroporation technology.
Product Format 1 vial of frozen cells
Quantity 2E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human FcγRIIIa(158V)
Gene ID/Uniprot ID P08637 (p.F176V)
Host Cell NK-92
Recovery Medium NK-92 cell-specific medium supplemented with 100 U/mL IL-2
Growth medium NK-92 cell-specific medium supplemented with 100 U/mL IL-2
Note Cells should be cultured using Procell-CM-0530 NK-92 Cell Culture Medium.
Freezing Medium 90% FBS+10% DMSO
Growth properties Suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Data Display
Expression
H_FCGR3A(CD16A) 158V NK-92 Cell Line (Cat. GM-C44572) was determined by flow cytometry using PE anti-human CD16 Antibody (Biolegend/302007).
Assay Performance
ADCC mediated by Raji and NK-92–derived cell lines was determined as the percentage of maximum LDH release from target cells. The ADCC FcγRIIIa(158V) NK-92 Cell Line (Cat. GM-C44572) at a density of 1×10⁵ cells/well was co-cultured with Raji Cell Line (Cat. GM-C19100) at a density of 2×10⁴ cells/well in a 96-well U-bottom plate. Serial dilutions of the Anti-H_MS4A1(CD20) hIgG1 Antibody(Cat. GM-27200AB) were added in assay buffer (RPMI 1640 + 1% FBS + 1% P.S). After 2 hours of incubation, LDH release was detected using the CytoTox 96®Non-Radioactive Cytotoxicity Assay (Promega/G1780).
Applications
Ocrelizumab-mediated ADCC assays on NK-92 cells. The ADCC FcγRIIIa(158V) NK-92 Cell Line Line(Cat. GM-C44572) at a density of 1E5 cells/well was co-cultured with Luciferase-ZsGreen1 Raji Cell Line (Cat. GM-C25554) at a density of 2E4 cells/well, in the presence of serial dilutions of the Anti-H_MS4A1(CD20) hIgG1 Antibody(Cat. GM-27200AB) in assay buffer (Specialized Culture Medium for NK-92 Cells, without IL-2) for 6 hours (96-well format). The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech).
CD107a degranulation flow cytometry validation. The ADCC FcγRIIIa(158V) NK-92 Cell Line (Cat. GM-C44572) was treated with Anti-H_MS4A1(CD20) hIgG1 Antibody(Cat. GM-27200AB) or PMA/Iono. FITC anti-human CD16 Antibody (Biolegend/302005) and Brilliant Violet 421™ anti-human CD107a (LAMP-1) Antibody (Biolegend/328625) were analyzed by flow cytometry. Groups: (A) C44572 unstained/unstimulated; (B) C44572+Raji; (C) C44572+Raji+Ocrelizumab; (D) C44572+PMA/Iono; (E) NK92+Raji+Ocrelizumab; (F) C44572+Raji+IgG control. Results show that FcγRIIIa(158V) NK-92 exhibits significant antibody-mediated degranulation, confirming effective ADCC triggering by the high-affinity variant.
Materials
Reagent Ordering Information
Specialized Culture Medium for NK-92 Cells Procell/CM-0530
PE anti-human CD16 Antibody BioLegend/302007
Anti-H_MS4A1(CD20) hIgG1 Antibody Genomeditech/GM-27200AB
FITC anti-human CD16 Antibody Biolegend/302005
APC anti-human CD56 (NCAM) Antibody Biolegend/318309
Brilliant Violet 421™ anti-human CD107a (LAMP-1) Antibody Biolegend/328625
Raji Cell Line Genomeditech/GM-C19100
CytoTox 96®Non-Radioactive Cytotoxicity Assay Promega/G1780
Countess 3 Automated Cell Counter ThermoFisher/A49891
NovoCyte Flow Cytometer Agilent/NovoCyte 2060R
SpectraMax® L Microplate Luminometer Moleculardevices/SpectraMax L
Reagent Ordering Information
Specialized Culture Medium for NK-92 Cells Procell/CM-0530
PE anti-human CD16 Antibody BioLegend/302007
Anti-H_MS4A1(CD20) hIgG1 Antibody Genomeditech/GM-27200AB
FITC anti-human CD16 Antibody Biolegend/302005
APC anti-human CD56 (NCAM) Antibody Biolegend/318309
Brilliant Violet 421™ anti-human CD107a (LAMP-1) Antibody Biolegend/328625
Raji Cell Line Genomeditech/GM-C19100
CytoTox 96®Non-Radioactive Cytotoxicity Assay Promega/G1780
Countess 3 Automated Cell Counter ThermoFisher/A49891
NovoCyte Flow Cytometer Agilent/NovoCyte 2060R
SpectraMax® L Microplate Luminometer Moleculardevices/SpectraMax L
Cell Culture

Cell Recovery

Recovery Medium: NK-92 cell-specific medium supplemented with 100 U/mL IL-2

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)      Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)      Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)         Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)         Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: NK-92 cell-specific medium supplemented with 100 U/mL IL-2

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)         Cell recovery after thawing is challenging, and initial cell growth is slow (approximately one week), with a subset of cells undergoing lysis, leading to a large number of dead cells and cellular debris. The culture condition usually improves after two weeks. It is recommended to centrifuge the culture at 176 × g for 5 minutes every 1–2 weeks to remove part of the cellular debris and particles by discarding the supernatant and replacing it with fresh recovery medium. Upon initial recovery, if the cells are not passaged within 48 hours, it is advisable to supplement the culture with additional recovery medium.

b)         When the cell density reaches 1.5–2E6 cells/mL, passage the cells at a 1:3 ratio, and continue subculturing every 2–3 days. Care should be taken not to allow the density to exceed 2E6 cells/mL. Passage cultures are recommended to be maintained in T25 flasks.

c)         Except for the first passage post-thaw (which requires centrifugation to collect cells), subsequent media changes or subculturing are preferably carried out using a half-medium change approach: allow the cells to settle by gravity, aspirate half of the spent medium, then add an equal volume of fresh medium to the flask. Gently pipette to resuspend the cells evenly or split them into two new T25 flasks at a 1:2 ratio, and then add fresh complete medium to a final volume of 8–10 mL per flask.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 3E5 and 1E6 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)         This cell line is highly sensitive to cell density. Please ensure that cell density is maintained within an appropriate range during cultivation and passaging.

b)         Cell growth is dependent on IL-2; in the absence of IL-2 in the culture medium, the cells are prone to rapid cell death. IL-2 is stable at -5 to -20°C and should be protected from repeated freeze-thaw cycles. Since IL-2 is prone to degradation, freshly prepared complete medium should be used within one week.

c)         Cells grow in clusters (cell aggregation). The presence of numerous cell debris and granules during the logarithmic growth phase is normal. When cell density becomes high or the culture medium turns yellow, partial or complete medium replacement should be performed promptly. During medium change, disperse the cell clusters as much as possible.

Cell Recovery

Recovery Medium: NK-92 cell-specific medium supplemented with 100 U/mL IL-2

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)      Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)      Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)         Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)         Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: NK-92 cell-specific medium supplemented with 100 U/mL IL-2

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)         Cell recovery after thawing is challenging, and initial cell growth is slow (approximately one week), with a subset of cells undergoing lysis, leading to a large number of dead cells and cellular debris. The culture condition usually improves after two weeks. It is recommended to centrifuge the culture at 176 × g for 5 minutes every 1–2 weeks to remove part of the cellular debris and particles by discarding the supernatant and replacing it with fresh recovery medium. Upon initial recovery, if the cells are not passaged within 48 hours, it is advisable to supplement the culture with additional recovery medium.

b)         When the cell density reaches 1.5–2E6 cells/mL, passage the cells at a 1:3 ratio, and continue subculturing every 2–3 days. Care should be taken not to allow the density to exceed 2E6 cells/mL. Passage cultures are recommended to be maintained in T25 flasks.

c)         Except for the first passage post-thaw (which requires centrifugation to collect cells), subsequent media changes or subculturing are preferably carried out using a half-medium change approach: allow the cells to settle by gravity, aspirate half of the spent medium, then add an equal volume of fresh medium to the flask. Gently pipette to resuspend the cells evenly or split them into two new T25 flasks at a 1:2 ratio, and then add fresh complete medium to a final volume of 8–10 mL per flask.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 3E5 and 1E6 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)         This cell line is highly sensitive to cell density. Please ensure that cell density is maintained within an appropriate range during cultivation and passaging.

b)         Cell growth is dependent on IL-2; in the absence of IL-2 in the culture medium, the cells are prone to rapid cell death. IL-2 is stable at -5 to -20°C and should be protected from repeated freeze-thaw cycles. Since IL-2 is prone to degradation, freshly prepared complete medium should be used within one week.

c)         Cells grow in clusters (cell aggregation). The presence of numerous cell debris and granules during the logarithmic growth phase is normal. When cell density becomes high or the culture medium turns yellow, partial or complete medium replacement should be performed promptly. During medium change, disperse the cell clusters as much as possible.

Sequence

  FcγRIIIa(158V) P08637(p.F176V):MWQLLLPTALLLLVSAGMRTEDLPKAVVFLEPQWYRVLEKDSVTLKCQGAYSPEDNSTQWFHNESLISSQASSYFIDAATVDDSGEYRCQTNLSTLSDPVQLEVHIGWLLLQAPRWVFKEEDPIHLRCHSWKNTALHKVTYLQNGKGRKYFHHNSDFYIPKATLKDSGSYFCRGLVGSKNVSSETVNITITQGLAVSTISSFFPPGYQVSFCLVMVLLFAVDTGLYFSVKTNIRSSTRDWKDHKFKWRKDPQDK

  FcγRIIIa(158V) P08637(p.F176V):MWQLLLPTALLLLVSAGMRTEDLPKAVVFLEPQWYRVLEKDSVTLKCQGAYSPEDNSTQWFHNESLISSQASSYFIDAATVDDSGEYRCQTNLSTLSDPVQLEVHIGWLLLQAPRWVFKEEDPIHLRCHSWKNTALHKVTYLQNGKGRKYFHHNSDFYIPKATLKDSGSYFCRGLVGSKNVSSETVNITITQGLAVSTISSFFPPGYQVSFCLVMVLLFAVDTGLYFSVKTNIRSSTRDWKDHKFKWRKDPQDK

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
ADCC FcγRIIIa(158V) NK-92 Cell Line
ADCC FcγRIIIa(158V) NK-92 Cell Line
Cat. No.
GM-C44572
Size
2 vials
Quote
Specifications
Data Display
Materials
Cell Culture
Sequence
Related products
Specifications
Cat. No GM-C44572
Product ADCC FcγRIIIa(158V) NK-92 Cell Line
Description ADCC FcγRIIIa(158V) NK-92 Cell Line is a clonal stable NK-92 cell line that constitutively expresses the Human FcγRIIIa(158V) gene, constructed using electroporation technology.
Product Format 1 vial of frozen cells
Quantity 2E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human FcγRIIIa(158V)
Gene ID/Uniprot ID P08637 (p.F176V)
Host Cell NK-92
Recovery Medium NK-92 cell-specific medium supplemented with 100 U/mL IL-2
Growth medium NK-92 cell-specific medium supplemented with 100 U/mL IL-2
Note Cells should be cultured using Procell-CM-0530 NK-92 Cell Culture Medium.
Freezing Medium 90% FBS+10% DMSO
Growth properties Suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C44572
Product ADCC FcγRIIIa(158V) NK-92 Cell Line
Description ADCC FcγRIIIa(158V) NK-92 Cell Line is a clonal stable NK-92 cell line that constitutively expresses the Human FcγRIIIa(158V) gene, constructed using electroporation technology.
Product Format 1 vial of frozen cells
Quantity 2E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human FcγRIIIa(158V)
Gene ID/Uniprot ID P08637 (p.F176V)
Host Cell NK-92
Recovery Medium NK-92 cell-specific medium supplemented with 100 U/mL IL-2
Growth medium NK-92 cell-specific medium supplemented with 100 U/mL IL-2
Note Cells should be cultured using Procell-CM-0530 NK-92 Cell Culture Medium.
Freezing Medium 90% FBS+10% DMSO
Growth properties Suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Data Display
Expression
H_FCGR3A(CD16A) 158V NK-92 Cell Line (Cat. GM-C44572) was determined by flow cytometry using PE anti-human CD16 Antibody (Biolegend/302007).
Assay Performance
ADCC mediated by Raji and NK-92–derived cell lines was determined as the percentage of maximum LDH release from target cells. The ADCC FcγRIIIa(158V) NK-92 Cell Line (Cat. GM-C44572) at a density of 1×10⁵ cells/well was co-cultured with Raji Cell Line (Cat. GM-C19100) at a density of 2×10⁴ cells/well in a 96-well U-bottom plate. Serial dilutions of the Anti-H_MS4A1(CD20) hIgG1 Antibody(Cat. GM-27200AB) were added in assay buffer (RPMI 1640 + 1% FBS + 1% P.S). After 2 hours of incubation, LDH release was detected using the CytoTox 96®Non-Radioactive Cytotoxicity Assay (Promega/G1780).
Applications
Ocrelizumab-mediated ADCC assays on NK-92 cells. The ADCC FcγRIIIa(158V) NK-92 Cell Line Line(Cat. GM-C44572) at a density of 1E5 cells/well was co-cultured with Luciferase-ZsGreen1 Raji Cell Line (Cat. GM-C25554) at a density of 2E4 cells/well, in the presence of serial dilutions of the Anti-H_MS4A1(CD20) hIgG1 Antibody(Cat. GM-27200AB) in assay buffer (Specialized Culture Medium for NK-92 Cells, without IL-2) for 6 hours (96-well format). The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech).
CD107a degranulation flow cytometry validation. The ADCC FcγRIIIa(158V) NK-92 Cell Line (Cat. GM-C44572) was treated with Anti-H_MS4A1(CD20) hIgG1 Antibody(Cat. GM-27200AB) or PMA/Iono. FITC anti-human CD16 Antibody (Biolegend/302005) and Brilliant Violet 421™ anti-human CD107a (LAMP-1) Antibody (Biolegend/328625) were analyzed by flow cytometry. Groups: (A) C44572 unstained/unstimulated; (B) C44572+Raji; (C) C44572+Raji+Ocrelizumab; (D) C44572+PMA/Iono; (E) NK92+Raji+Ocrelizumab; (F) C44572+Raji+IgG control. Results show that FcγRIIIa(158V) NK-92 exhibits significant antibody-mediated degranulation, confirming effective ADCC triggering by the high-affinity variant.
Materials
Reagent Ordering Information
Specialized Culture Medium for NK-92 Cells Procell/CM-0530
PE anti-human CD16 Antibody BioLegend/302007
Anti-H_MS4A1(CD20) hIgG1 Antibody Genomeditech/GM-27200AB
FITC anti-human CD16 Antibody Biolegend/302005
APC anti-human CD56 (NCAM) Antibody Biolegend/318309
Brilliant Violet 421™ anti-human CD107a (LAMP-1) Antibody Biolegend/328625
Raji Cell Line Genomeditech/GM-C19100
CytoTox 96®Non-Radioactive Cytotoxicity Assay Promega/G1780
Countess 3 Automated Cell Counter ThermoFisher/A49891
NovoCyte Flow Cytometer Agilent/NovoCyte 2060R
SpectraMax® L Microplate Luminometer Moleculardevices/SpectraMax L
Reagent Ordering Information
Specialized Culture Medium for NK-92 Cells Procell/CM-0530
PE anti-human CD16 Antibody BioLegend/302007
Anti-H_MS4A1(CD20) hIgG1 Antibody Genomeditech/GM-27200AB
FITC anti-human CD16 Antibody Biolegend/302005
APC anti-human CD56 (NCAM) Antibody Biolegend/318309
Brilliant Violet 421™ anti-human CD107a (LAMP-1) Antibody Biolegend/328625
Raji Cell Line Genomeditech/GM-C19100
CytoTox 96®Non-Radioactive Cytotoxicity Assay Promega/G1780
Countess 3 Automated Cell Counter ThermoFisher/A49891
NovoCyte Flow Cytometer Agilent/NovoCyte 2060R
SpectraMax® L Microplate Luminometer Moleculardevices/SpectraMax L
Cell Culture

Cell Recovery

Recovery Medium: NK-92 cell-specific medium supplemented with 100 U/mL IL-2

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)      Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)      Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)         Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)         Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: NK-92 cell-specific medium supplemented with 100 U/mL IL-2

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)         Cell recovery after thawing is challenging, and initial cell growth is slow (approximately one week), with a subset of cells undergoing lysis, leading to a large number of dead cells and cellular debris. The culture condition usually improves after two weeks. It is recommended to centrifuge the culture at 176 × g for 5 minutes every 1–2 weeks to remove part of the cellular debris and particles by discarding the supernatant and replacing it with fresh recovery medium. Upon initial recovery, if the cells are not passaged within 48 hours, it is advisable to supplement the culture with additional recovery medium.

b)         When the cell density reaches 1.5–2E6 cells/mL, passage the cells at a 1:3 ratio, and continue subculturing every 2–3 days. Care should be taken not to allow the density to exceed 2E6 cells/mL. Passage cultures are recommended to be maintained in T25 flasks.

c)         Except for the first passage post-thaw (which requires centrifugation to collect cells), subsequent media changes or subculturing are preferably carried out using a half-medium change approach: allow the cells to settle by gravity, aspirate half of the spent medium, then add an equal volume of fresh medium to the flask. Gently pipette to resuspend the cells evenly or split them into two new T25 flasks at a 1:2 ratio, and then add fresh complete medium to a final volume of 8–10 mL per flask.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 3E5 and 1E6 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)         This cell line is highly sensitive to cell density. Please ensure that cell density is maintained within an appropriate range during cultivation and passaging.

b)         Cell growth is dependent on IL-2; in the absence of IL-2 in the culture medium, the cells are prone to rapid cell death. IL-2 is stable at -5 to -20°C and should be protected from repeated freeze-thaw cycles. Since IL-2 is prone to degradation, freshly prepared complete medium should be used within one week.

c)         Cells grow in clusters (cell aggregation). The presence of numerous cell debris and granules during the logarithmic growth phase is normal. When cell density becomes high or the culture medium turns yellow, partial or complete medium replacement should be performed promptly. During medium change, disperse the cell clusters as much as possible.

Cell Recovery

Recovery Medium: NK-92 cell-specific medium supplemented with 100 U/mL IL-2

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)      Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)      Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)         Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)         Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: NK-92 cell-specific medium supplemented with 100 U/mL IL-2

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)         Cell recovery after thawing is challenging, and initial cell growth is slow (approximately one week), with a subset of cells undergoing lysis, leading to a large number of dead cells and cellular debris. The culture condition usually improves after two weeks. It is recommended to centrifuge the culture at 176 × g for 5 minutes every 1–2 weeks to remove part of the cellular debris and particles by discarding the supernatant and replacing it with fresh recovery medium. Upon initial recovery, if the cells are not passaged within 48 hours, it is advisable to supplement the culture with additional recovery medium.

b)         When the cell density reaches 1.5–2E6 cells/mL, passage the cells at a 1:3 ratio, and continue subculturing every 2–3 days. Care should be taken not to allow the density to exceed 2E6 cells/mL. Passage cultures are recommended to be maintained in T25 flasks.

c)         Except for the first passage post-thaw (which requires centrifugation to collect cells), subsequent media changes or subculturing are preferably carried out using a half-medium change approach: allow the cells to settle by gravity, aspirate half of the spent medium, then add an equal volume of fresh medium to the flask. Gently pipette to resuspend the cells evenly or split them into two new T25 flasks at a 1:2 ratio, and then add fresh complete medium to a final volume of 8–10 mL per flask.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 3E5 and 1E6 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)         This cell line is highly sensitive to cell density. Please ensure that cell density is maintained within an appropriate range during cultivation and passaging.

b)         Cell growth is dependent on IL-2; in the absence of IL-2 in the culture medium, the cells are prone to rapid cell death. IL-2 is stable at -5 to -20°C and should be protected from repeated freeze-thaw cycles. Since IL-2 is prone to degradation, freshly prepared complete medium should be used within one week.

c)         Cells grow in clusters (cell aggregation). The presence of numerous cell debris and granules during the logarithmic growth phase is normal. When cell density becomes high or the culture medium turns yellow, partial or complete medium replacement should be performed promptly. During medium change, disperse the cell clusters as much as possible.

Sequence

  FcγRIIIa(158V) P08637(p.F176V):MWQLLLPTALLLLVSAGMRTEDLPKAVVFLEPQWYRVLEKDSVTLKCQGAYSPEDNSTQWFHNESLISSQASSYFIDAATVDDSGEYRCQTNLSTLSDPVQLEVHIGWLLLQAPRWVFKEEDPIHLRCHSWKNTALHKVTYLQNGKGRKYFHHNSDFYIPKATLKDSGSYFCRGLVGSKNVSSETVNITITQGLAVSTISSFFPPGYQVSFCLVMVLLFAVDTGLYFSVKTNIRSSTRDWKDHKFKWRKDPQDK

  FcγRIIIa(158V) P08637(p.F176V):MWQLLLPTALLLLVSAGMRTEDLPKAVVFLEPQWYRVLEKDSVTLKCQGAYSPEDNSTQWFHNESLISSQASSYFIDAATVDDSGEYRCQTNLSTLSDPVQLEVHIGWLLLQAPRWVFKEEDPIHLRCHSWKNTALHKVTYLQNGKGRKYFHHNSDFYIPKATLKDSGSYFCRGLVGSKNVSSETVNITITQGLAVSTISSFFPPGYQVSFCLVMVLLFAVDTGLYFSVKTNIRSSTRDWKDHKFKWRKDPQDK

Contact
Us
Message Inquiry
reset
submit
Message
Message Inquiry
reset
submit